A composite ranking of risk factors for COVID-19 time-to-event data from a Turkish cohort
- PMID: 35487152
- PMCID: PMC8993420
- DOI: 10.1016/j.compbiolchem.2022.107681
A composite ranking of risk factors for COVID-19 time-to-event data from a Turkish cohort
Abstract
Having a complete and reliable list of risk factors from routine laboratory blood test for COVID-19 disease severity and mortality is important for patient care and hospital management. It is common to use meta-analysis to combine analysis results from different studies to make it more reproducible. In this paper, we propose to run multiple analyses on the same set of data to produce a more robust list of risk factors. With our time-to-event survival data, the standard survival analysis were extended in three directions. The first is to extend from tests and corresponding p-values to machine learning and their prediction performance. The second is to extend from single-variable to multiple-variable analysis. The third is to expand from analyzing time-to-decease data with death as the event of interest to analyzing time-to-hospital-release data to treat early recovery as a meaningful event as well. Our extension of the type of analyses leads to ten ranking lists. We conclude that 20 out of 30 factors are deemed to be reliably associated to faster-death or faster-recovery. Considering correlation among factors and evidenced by stepwise variable selection in random survival forest, 10 ~ 15 factors seem to be able to achieve the optimal prognosis performance. Our final list of risk factors contain calcium, white blood cell and neutrophils count, urea and creatine, d-dimer, red cell distribution widths, age, ferritin, glucose, lactate dehydrogenase, lymphocyte, basophils, anemia related factors (hemoglobin, hematocrit, mean corpuscular hemoglobin concentration), sodium, potassium, eosinophils, and aspartate aminotransferase.
Keywords: COVID-19; Competing risks; Composite ranking; Survival analysis.
Copyright © 2022 Elsevier Ltd. All rights reserved.
Conflict of interest statement
There is no conflict of interest to declare.
Figures




Similar articles
-
Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II).Trials. 2020 Jun 12;21(1):520. doi: 10.1186/s13063-020-04380-5. Trials. 2020. PMID: 32532356 Free PMC article.
-
Temporal changes in laboratory markers of survivors and non-survivors of adult inpatients with COVID-19.BMC Infect Dis. 2020 Dec 11;20(1):952. doi: 10.1186/s12879-020-05678-0. BMC Infect Dis. 2020. PMID: 33308159 Free PMC article.
-
[Clinical features and risk factors for secondary hemophagocytic lymphohistiocytosis in elderly patients with severe SARS-CoV-2 infection: a multicenter retrospective cohort study].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023 Aug;35(8):793-799. doi: 10.3760/cma.j.cn121430-20230510-00158. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023. PMID: 37593855 Chinese.
-
Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis.Eur J Med Res. 2020 Aug 3;25(1):30. doi: 10.1186/s40001-020-00432-3. Eur J Med Res. 2020. PMID: 32746929 Free PMC article.
-
Laboratory Tests and Outcome for Patients with Coronavirus Disease 2019: A Systematic Review and Meta-Analysis.J Appl Lab Med. 2020 Sep 1;5(5):1038-1049. doi: 10.1093/jalm/jfaa098. J Appl Lab Med. 2020. PMID: 32573713 Free PMC article.
Cited by
-
Diabetes and bacterial co-infection are two independent risk factors for respiratory syncytial virus disease severity.Front Med (Lausanne). 2023 Nov 1;10:1231641. doi: 10.3389/fmed.2023.1231641. eCollection 2023. Front Med (Lausanne). 2023. PMID: 38020119 Free PMC article.
-
Blood-Type-A is a COVID-19 infection and hospitalization risk in a Turkish cohort.Transfus Clin Biol. 2023 Feb;30(1):116-122. doi: 10.1016/j.tracli.2022.10.003. Epub 2022 Oct 13. Transfus Clin Biol. 2023. PMID: 36243305 Free PMC article.
References
-
- Aljameel S.S., Khan I.U., Aslam N., Aljabri M., Alsulmi E.S. Machine learning-based model to predict the disease severity and outcome in COVID-19 patients. Sci. Program. 2021;2021
-
- Allison P. Event History Analysis: Regression for Longitudinal Event Data. 2nd edition. SAGE Publications; 2014.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical